Monthly Archives: August 2015
Commercial Eyes recruiting: Administrative Assistant
Commercial Eyes is looking for a full time Administrative Assistant to join our Market Access team. Based in the Melbourne CBD this role requires excellent administrative skills, and a proficiency with Microsoft Office and desktop publishing. For more information about … Continue reading
Commercial Eyes recruiting: Accounts Support, Finance Department
Commercial Eyes has a part time Accounts Support vacancy in our Finance Department. Applicants should have a minimum of 1-2 years experience, strong communication and time management skills. This job is based in the Melbourne CBD and would suit someone … Continue reading
A PV database to meet your needs… and your budget
Just as medicines and medical devices are held to stringent quality controls, so too is the software used to support the safety and efficacy of those same medicines and medical devices. Choosing a pharmacovigilance (PV) database for your business can … Continue reading
The 3R’s of Clinical Trials: Recruitment-Retention-Reward
Did you know that less than 10% of clinical studies are completed on time? In fact, 94% of trials are delayed by over one month. Although this doesn’t sound like a significant delay, it has been estimated that for each … Continue reading
Is nothing safe from price reduction?
As of 1 April 2016, all F1 medicines that have been on the PBS for five years will take a 5% price cut. Originator brands will be removed from the weighted average disclosed price (WADP) calculations from the cycle commencing … Continue reading
Commercial Eyes recruiting: Project Team Leader – Medical Services
We are looking to hire a Project Team Leader for our Medical Services team. This is a temporary, 12 month maternity leave position, based in the Melbourne CBD. Applicants should have experience in Medical Affairs, proven team management capabilities and … Continue reading
Launch sequencing and the 5% F1 price cut: strategic considerations for your patented medicine
Achieving optimal prices for patented medicines is a critical issue close to the heart of the pharmaceutical industry. The 2015/16 Federal Budget introduced new savings measures with implications for prices of patented medicines in Australia. In the current environment, launch … Continue reading
